SCHEMBL10183722

SCHEMBL10183722

Cn1ccc(N(C(=O)Cc2cn(C)c3ccccc23)C2C(=O)N(C3CCCCC3)c3ccccc32)n1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 4/20 0.41
▸ MAPT P10636 3/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ HTT P42858 3/20 0.36
▸ ALDH1A1 P00352 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ OPRM1 P35372 2/20 0.35
▸ OPRK1 P41145 2/20 0.35
▸ OPRL1 P41146 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ACKR3 P25106 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10183271 0.85 MAPT (0.42) TP53MAPTPOLBALDH1A1SMN1; SMN2
SCHEMBL10183925 0.82 TP53 (0.41) TP53MAPTKDM4EPOLBHTT
SCHEMBL10183670 0.81 TRPM8 (0.41) POLBNPSR1OPRM1OPRK1OPRL1
SCHEMBL10183302 0.79 PTAFR (0.41) MAPTPOLBHTTALDH1A1SMN1; SMN2
SCHEMBL10184173 0.78 OPRM1 (0.37) KDM4EKMT2AOPRM1OPRK1OPRL1
SCHEMBL10183929 0.77 CHRM2 (0.43) MAPTKDM4EALDH1A1MEN1KMT2A
SCHEMBL10185835 0.70 TSHR (0.38) MAPTPOLBHTTALDH1A1SMN1; SMN2
SCHEMBL15119061 0.68 IDH1 (0.47) KDM4EHTTMEN1KMT2ALMNA
SCHEMBL10184164 0.66 ACKR3 (0.35) TP53MAPTOPRM1OPRK1OPRL1
SCHEMBL10183227 0.65 MAPT (0.42) TP53MAPTKDM4EPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012009678-A1 THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE AGIOS PHARMACEUTICALS, INC. (US) 2012-01-19 — — WO disclosed
Send feedback